The development of imatinib as a therapeutic agent for sorted by
relevance

Admin13.07.2021

The development of imatinib as a therapeutic agent for

3809
Admin25.07.2021

(PDF) Development of peptide inhibitor as a therapeutic

904
Admin13.09.2021

(PDF) Cardiotoxicity of the cancer therapeutic agent

Admin07.10.2021

The development of imatinib as a therapeutic agent for

8009
Admin30.09.2021

The development of imatinib as a therapeutic agent for

2509
Admin29.08.2021

In reply to Cardiotoxicity of the cancer therapeutic

9405
Admin17.09.2021

The development of imatinib as a therapeutic agent for

42010
Admin07.10.2021

(PDF) Endometrial Cancer: Molecular and Cellular Basis of

8701
Admin23.09.2021

(PDF) Clinical relevance of vascular endothelial growth

Admin17.08.2021

(PDF) Expression differences of miR-142-5p between

3103
Admin18.08.2021

The development of imatinib as a therapeutic agent for

6503
Admin04.10.2021

The development of imatinib as a therapeutic agent for

7502
Admin20.08.2021

$1.5M NIH Grant Supports Development of Therapeutic Agent

6301
Admin16.07.2021

[Full text] Resistant mutations in CML and Ph+ALL - role

5806
Admin16.08.2021

PPT - Development of Therapeutic Agents Based on the GLP-1

3204
Admin17.09.2021

Imatinib resistance in chronic myeloid leukaemia caused by

5308
Admin24.08.2021

High-sensitivity detection of BCR-ABL kinase domain

4408
Admin20.07.2021

Cardiotoxicity of the cancer therapeutic agent imatinib

904
Admin13.07.2021

(PDF) Potential opportunity in the development of new

1202
Admin22.07.2021

5MJCB4-TKI

7205
Admin21.09.2021

IMATINIB Synthesis, SAR, MCQ,Structure,Chemical Properties

4501